The Vanguard Group, Inc. recently announced the acquisition of new stake in Mondelez International Inc. (NASDAQ:MDLZ). The institutional investor has increased its shareholding in the Consumer Defensive company by 0.01% to 117.92 million shares with purchase of 16012.0 shares. This fresh investment now brings its stake to 8.66% valued currently at $8.54 billion. In addition, T. Rowe Price Associates, Inc. raised its holdings by 3.93 million to 32.9 million shares. And Geode Capital Management LLC has lifted its position by 1.80% or 0.46 million shares – to 26.25 million shares.
Currently, there are 1.37B common shares owned by the public and among those 1.36B shares have been available to trade.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Insiders at the company have transacted a total of 27 times over the past 12 months, according to data filed with the U.S. Securities and Exchange Commission (SEC). 18 of these insider trades were purchases, accounting for 512,598 shares. Insider sales of the common stock occurred on 9 occasions, with total insider shares sold totaling 190,802 shares.
The top 3 mutual fund holders in Mondelez International Inc. are Vanguard Total Stock Market ETF, Vanguard 500 Index Fund, and Invesco QQQ Trust. Vanguard Total Stock Market ETF owns 42.73 million shares of the company’s stock, all valued at over $3.09 billion. The company bought an additional 88397.0 shares recently to bring their total holdings to about 3.14% of the shares outstanding. Vanguard 500 Index Fund bought 64260.0 shares to see its total holdings expand to 33.22 million shares valued at over $2.41 billion and representing 2.44% of the shares outstanding. Invesco QQQ Trust sold 64235.0 shares to bring its total holdings to over 25.03 million shares at a value of $1.81 billion. Invesco QQQ Trust now owns shares totaling to 1.84% of the shares outstanding.
However, the script later moved the day high at 74.61, up 1.76%. The company’s stock has a 5-day price change of 2.14% and 16.08% over the past three months. MDLZ shares are trading 2.73% year to date (YTD), with the 12-month market performance up to 16.19% higher. It has a 12-month low price of $60.75 and touched a high of $78.59 over the same period. MDLZ has an average intraday trading volume of 6.11 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by 2.27%, 3.95%, and 3.91% respectively.
Institutional ownership of Mondelez International Inc. (NASDAQ: MDLZ) shares accounts for 79.36% of the company’s 1.37B shares outstanding. Mutual fund holders own 33.65%, while other institutional holders and individual stakeholders account for 45.95% and 0.75% respectively.
It has a market capitalization of $101.26B and a beta (3y monthly) value of 0.59. The stock’s trailing 12-month PE ratio is 22.24, while the earnings-per-share (ttm) stands at $3.35. The company has a PEG of 2.46 and a Quick Ratio of 0.41 with the debt-to-equity ratio at 0.72. Price movements for the stock have been influenced by the stock’s volatility, which stands at 1.23% over the week and 1.22% over the month.
Analysts forecast that Mondelez International Inc. (MDLZ) will achieve an EPS of $0.77 for the current quarter, $0.94 for the next quarter and $3.51 for 2024. The lowest estimate earnings-per-share for the quarter is $0.73 while analysts give the company a high EPS estimate of $0.84. Comparatively, EPS for the current quarter was $0.73 a year ago. Earnings per share for the fiscal year are expected to increase by 9.80%, and 8.40% over the next financial year. EPS should grow at an annualized rate of 9.04% over the next five years, compared to 1.21% over the past 5-year period.
Looking at the support for the MDLZ, a number of firms have released research notes about the stock. Deutsche Bank stated their Buy rating for the stock in a research note on January 18, 2024, with the firm’s price target at $78-$80.
